Literature DB >> 24554983

Feasibility of nephron-sparing surgery in giant oncocytoma.

Albert El Hajj1, Ruban Thanigasalam2, Isabelle Boulay3, Vincent Molinié4, Bernard Escudier5, Hervé Baumert2.   

Abstract

Oncocytomas represent 3 to 7% of renal masses and behave as benign tumours. Nephron-sparing procedures are preferred for biopsy confirmed lesions; however, giant oncocytomas have been generally treated by radical nephrectomy. We report the first case of partial nephrectomy in a 45-year-old man who presented with a 20-cm oncocytoma. At the 1 year follow-up, he had a normal functioning kidney. Despite the difficulty of this procedure, partial nephrectomy for very large benign tumours can be considered in appropriately selected young patients.

Entities:  

Year:  2014        PMID: 24554983      PMCID: PMC3926935          DOI: 10.5489/cuaj.1552

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  10 in total

1.  Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.

Authors:  B Cochand-Priollet; V Molinié; J Bougaran; R Bouvier; M C Dauge-Geffroy; S Deslignières; J C Fournet; P Gros; A Lesourd; J P Saint-André; M Toublanc; A Vieillefond; M Wassef; A Fontaine; L Groleau
Journal:  Arch Pathol Lab Med       Date:  1997-10       Impact factor: 5.534

2.  Reducing warm ischaemia time during laparoscopic partial nephrectomy: a prospective comparison of two renal closure techniques.

Authors:  Hervé Baumert; Andrew Ballaro; Nimish Shah; Dhouha Mansouri; Nauman Zafar; Vincent Molinié; David Neal
Journal:  Eur Urol       Date:  2007-03-28       Impact factor: 20.096

3.  MRI features of renal oncocytoma and chromophobe renal cell carcinoma.

Authors:  Andrew B Rosenkrantz; Nicole Hindman; Erin F Fitzgerald; Benjamin E Niver; Jonathan Melamed; James S Babb
Journal:  AJR Am J Roentgenol       Date:  2010-12       Impact factor: 3.959

4.  Is segmental enhancement inversion on enhanced biphasic MDCT a reliable sign for the noninvasive diagnosis of renal oncocytomas?

Authors:  John P McGahan; Ramit Lamba; Jerron Fisher; Phillip Starshak; Rajendra Ramsamooj; Evan Fitzgerald; Philip Yen
Journal:  AJR Am J Roentgenol       Date:  2011-10       Impact factor: 3.959

Review 5.  Molecular pathology of renal oncocytoma: a review.

Authors:  Maria V Yusenko
Journal:  Int J Urol       Date:  2010-07       Impact factor: 3.369

Review 6.  Renal oncocytoma: a review of histogenesis, histopathology, diagnosis and treatment.

Authors:  M N Morra; S Das
Journal:  J Urol       Date:  1993-08       Impact factor: 7.450

7.  [Renal oncocytoma: CT diagnostic criteria revisited].

Authors:  D Eiss; F Larousserie; A Mejean; M Ghouadni; S Merran; J M Correas; O Hélénon
Journal:  J Radiol       Date:  2005-12

8.  Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillance.

Authors:  Sarah Kawaguchi; Kimberly A Fernandes; Antonio Finelli; Michael Robinette; Neil Fleshner; Michael A S Jewett
Journal:  J Urol       Date:  2011-08-17       Impact factor: 7.450

9.  Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma.

Authors:  C B Dechet; D G Bostwick; M L Blute; S C Bryant; H Zincke
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

10.  Percutaneous core biopsy for renal masses: indications, accuracy and results.

Authors:  Thierry Lebret; Jean Eudes Poulain; Vincent Molinie; Jean Marie Herve; Yves Denoux; Axel Guth; Antoine Scherrer; Henry Botto
Journal:  J Urol       Date:  2007-08-14       Impact factor: 7.450

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.